نتایج جستجو برای: urothelial carcinoma in situ

تعداد نتایج: 17047993  

2017
Qiuyang Li Jie Tang Enhui He Yanmi Li Yun Zhou Baojun Wang

PURPOSE To evaluate the value of contrast-enhanced ultrasonography (CEUS) in the differentiation of high and low grade urothelial carcinoma. MATERIALS AND METHODS 192 with 192 bladder lesions, including 110 high grade urothelial carcinoma and 82 low grade urothelial carcinoma were examined by CEUS. Among 192 tumors, enhancement patterns of 96 tumors between August 2010 and December 2012 were ...

2011

Urinary cytology has a well-established role in the detection and monitoring of urothelial carcinoma. The main strength of cytology is the high specificity for high-grade urothelial carcinoma and carcinoma in situ, but it has a low sensitivity for low-grade, non-invasive tumors. There are several other limitations of cytology. Cytology of the upper urinary tract and after intravesical therapy w...

2011

Urinary cytology has a well-established role in the detection and monitoring of urothelial carcinoma. The main strength of cytology is the high specificity for high-grade urothelial carcinoma and carcinoma in situ, but it has a low sensitivity for low-grade, non-invasive tumors. There are several other limitations of cytology. Cytology of the upper urinary tract and after intravesical therapy w...

عسگری, مژگان, نوری, صغری,

ABSTRACT Bladder cancer consists of about 5.2% of all cancers in men and 2.3% in women. About 90% of them have the origin of transitional cells(TCC). There are some predictive factors that knowledge of them is useful for management and follow-up of the patients. Expression of oncoprotein P53 is one of these factors. Considering influence of P53 expression on prognosis, we decided ...

Journal: :Cancer research 2009
Chao-Nan Qian Kyle A Furge Jared Knol Dan Huang Jindong Chen Karl J Dykema Eric J Kort Aaron Massie Sok Kean Khoo Kristin Vanden Beldt James H Resau John Anema Richard J Kahnoski Hans Morreau Philippe Camparo Eva Comperat Mathilde Sibony Yves Denoux Vincent Molinie Annick Vieillefond Charis Eng Bart O Williams Bin Tean Teh

Urothelial carcinoma of the renal pelvis is a deadly disease with an unclear tumorigenic mechanism. We conducted gene expression profiling on a set of human tumors of this type and identified a phosphatidylinositol 3-kinase (PI3K)/AKT activation expression signature in 76.9% (n = 13) of our samples. Sequence analysis found both activating mutations of PIK3CA (13.6%, n = 22) and loss of heterozy...

2012
Wei-Pin Chang Tsu-Ming Chien Yu-Shiuan Wang Siou-Jin Chiu Mei-Hui Lee Wei-Chiao Chang Yii-Her Chou Ming-Feng Hou

INTRODUCTION A primary ureteral stump tumor after a nephrectomy is rare; urothelial carcinoma of the ureteral stump after a nephrectomy for renal cell carcinoma is even rarer. A thorough review of the literature indicated that only seven cases have previously been reported. In this study, we report the first Taiwanese case of urothelial carcinoma of the ureteral stump after a nephrectomy. It is...

2017
Kyosuke Matsuzaki Kazutoshi Fujita Kentaro Jingushi Atsunari Kawashima Takeshi Ujike Akira Nagahara Yuko Ueda Go Tanigawa Iwao Yoshioka Koji Ueda Rikinari Hanayama Motohide Uemura Yasushi Miyagawa Kazutake Tsujikawa Norio Nonomura

BACKGROUND Extracellular vesicles are lipid bilayer vesicles containing protein, messengerRNA and microRNA. Cancer cell-derived extracellular vesicles may be diagnostic and therapeutic targets. We extracted extracellular vesicles from urine of urothelial carcinoma patients and the control group to identify cancer-specific microRNAs in urinary extracellular vesicles as new biomarkers. MATERIAL...

Journal: :Archivos espanoles de urologia 2005
Alejandro Rodriguez David Burday Wade Sexton Nazeel Ahmad Julio M Pow-Sang

OBJECTIVES Urothelial carcinoma of the bladder occurs rarely in the first 2 decades of life. We report a case of a 12 year-old child that presented with a Ta grade II/III urothelial carcinoma of the bladder. METHODS We describe its clinical presentation and diagnostic procedures as well as treatment and follow-up. Finally, we review the literature to analyze the etiology, treatment, and surve...

Journal: :American journal of clinical pathology 2012
Eric J Fichtenbaum William L Marsh Debra L Zynger

For primary bladder tumors, distinguishing urothelial carcinoma (UC) invading the fibromuscular stroma of the prostate (pT4a) from in situ UC involving prostatic ducts can be difficult. Immunohistochemical markers (cytokeratin [CK]5/6, CK5, CK7, CK20, p53, p63, high-molecular-weight keratin [HMWK], androgen receptor, prostate-specific antigen [PSA], prostate specific acid phosphatase [PSAP], la...

Journal: :European urology 2016
Peter A Humphrey Holger Moch Antonio L Cubilla Thomas M Ulbright Victor E Reuter

UNLABELLED It has been 12 yr since the publication of the last World Health Organization (WHO) classification of tumours of the prostate and bladder. During this time, significant new knowledge has been generated about the pathology and genetics of these tumours. Intraductal carcinoma of the prostate is a newly recognized entity in the 2016 WHO classification. In most cases, it represents intra...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید